Acorah Software Products - Accounts Production 16.5.460 false true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 09645705 Dr Peter Uwechue Dr Monisola Uwechue iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09645705 2024-03-31 09645705 2025-03-31 09645705 2024-04-01 2025-03-31 09645705 frs-core:CurrentFinancialInstruments 2025-03-31 09645705 frs-core:ComputerEquipment 2025-03-31 09645705 frs-core:ComputerEquipment 2024-04-01 2025-03-31 09645705 frs-core:ComputerEquipment 2024-03-31 09645705 frs-core:FurnitureFittings 2025-03-31 09645705 frs-core:FurnitureFittings 2024-04-01 2025-03-31 09645705 frs-core:FurnitureFittings 2024-03-31 09645705 frs-core:ShareCapital 2025-03-31 09645705 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 09645705 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09645705 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 09645705 frs-bus:SmallEntities 2024-04-01 2025-03-31 09645705 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 09645705 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 09645705 frs-bus:Director1 2024-04-01 2025-03-31 09645705 frs-bus:Director1 2024-03-31 09645705 frs-bus:Director1 2025-03-31 09645705 frs-bus:Director2 2024-04-01 2025-03-31 09645705 frs-countries:EnglandWales 2024-04-01 2025-03-31 09645705 2023-03-31 09645705 2024-03-31 09645705 2023-04-01 2024-03-31 09645705 frs-core:CurrentFinancialInstruments 2024-03-31 09645705 frs-core:ShareCapital 2024-03-31 09645705 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31
Registered number: 09645705
Pemon Medical Limited
Financial Statements
For The Year Ended 31 March 2025
Pemon Medical Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Notes to the Financial Statements | 3—5

Page 1
Pemon Medical Limited
Balance Sheet
As At 31 March 2025
Balance Sheet
Registered number: 09645705

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Tangible Assets | 4 |  | 2,458 |  | 1,621
|  |  | 2,458 |  | 1,621
CURRENT ASSETS
Debtors | 5 | 44,508 |  | 23,241 |
Cash at bank and in hand |  | 4,937 |  | 10,482 |
|  | 49,445 |  | 33,723 |
Creditors: Amounts Falling Due Within One Year | 6 | (16,368 ) |  | (15,622 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 33,077 |  | 18,101
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 35,535 |  | 19,722
NET ASSETS |  |  | 35,535 |  | 19,722
CAPITAL AND RESERVES
Called up share capital | 7 |  | 2 |  | 2
Profit and Loss Account |  |  | 35,533 |  | 19,720
SHAREHOLDERS' FUNDS |  |  | 35,535 |  | 19,722

Page 1
Page 2
Pemon Medical Limited
Balance Sheet (continued)
As At 31 March 2025
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Dr Monisola Uwechue Director
24 October 2025

The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Pemon Medical Limited
Notes to the Financial Statements
For The Year Ended 31 March 2025
Notes to the Financial Statements
1. General Information
Pemon Medical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 09645705 . The registered office is Damer House, Meadow Way, Wickford, Essex, SS12 9HA.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added taxes, and other similar allowances.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Fixtures & Fittings | 20% Straight line
Computer Equipment | 25%/33.33% Straight line

2.4. Taxation
Taxation represents the sum of the tax currently payable and deferred tax.
The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.
3. Average Number of Employees
The average number of employees, including directors, during the year was as follows: 2 (2024: 2)
2 2
Page 3
Page 4
Pemon Medical Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 March 2025
4. Tangible Assets

| Fixtures & Fittings | Computer Equipment | Total
--- | --- | --- | ---
| £ | £ | £
Cost
As at 1 April 2024 | 3,517 | 3,286 | 6,803
Additions | - | 2,347 | 2,347
As at 31 March 2025 | 3,517 | 5,633 | 9,150
Depreciation
As at 1 April 2024 | 2,512 | 2,670 | 5,182
Provided during the period | 460 | 1,050 | 1,510
As at 31 March 2025 | 2,972 | 3,720 | 6,692
Net Book Value
As at 31 March 2025 | 545 | 1,913 | 2,458
As at 1 April 2024 | 1,005 | 616 | 1,621

5. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Trade debtors | 7,885 |  | 6,885
Other debtors | 36,623 |  | 16,356
| 44,508 |  | 23,241

6. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Trade creditors | 770 |  | 715
Other creditors | 1,500 |  | 2,073
Taxation and social security | 14,098 |  | 12,834
| 16,368 |  | 15,622

7. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 2 |  | 2

Page 4
Page 5
Pemon Medical Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 March 2025
8. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:

| As at 1 April 2024 | Amounts advanced | Amounts repaid | Amounts written off | As at 31 March 2025
--- | --- | --- | --- | --- | ---
| £ | £ | £ | £ | £
Dr Monisola Uwechue | 16,356 | 35,861 | 16,356 | - | 35,861

The above loan is unsecured, interest free and repayable on demand.
Page 5